Add BrightSurf on Google Email

Science News Archive 2019 - Page 223


Page 223 of 486

A genomic barcode tracker for immune cells

A new method, RAGE-seq, enables scientists to track rare immune cells reactive against cancer cells. The technique reveals unprecedented insight into armming the immune system to target cancer. By scanning thousands of immune cells at a time, it provides an accurate snapshot of how the immune cells in a tissue sample are related.

SourceGarvan Institute of Medical Research·JournalNature Communications·DateJul 16, 2019

Fusion's path to practicality

TAE Technologies, backed by DOE funding through INCITE program, aims to achieve commercially viable nuclear fusion energy. The company's FRC device seeks to confine plasma at high temperatures for extended periods, paving the way for sustainable, carbon-free energy production.

Prescribed opioids associated with overdose risk for family members without prescriptions

A new study by Brigham and Women's Hospital found that prescribed opioids are associated with a nearly threefold increase in overdose rates for individuals without their own prescriptions. Family members on the same health insurance plan have access to these medications, posing a significant risk of accidental exposure or misuse.

SourceBrigham and Women's Hospital·JournalJAMA Internal Medicine·DateJul 16, 2019

Global commission into health inequities of mental illness gives blueprint for change

A global commission has released a blueprint for protecting physical health in people with mental illness, highlighting key factors driving poor health and presenting initiatives for health policy and clinical services. The report reveals a broad range of mental illnesses are associated with obesity, diabetes, and cardiovascular disease.

Study identifies potential markers of lung cancer

Researchers at Massachusetts General Hospital have identified markers that can distinguish between major subtypes of lung cancer and accurately predict lung cancer stage. The study's findings could help physicians decide whether an individual patient with lung cancer benefits from standard treatment or needs more aggressive therapy.

SourceMassachusetts General Hospital·JournalScientific Reports·DateJul 16, 2019